|
|
|
Volumn 60, Issue SUPPL. 19, 1999, Pages 3-4
|
|
Antipsychotic agents: Clinical, economic, and legal considerations in the treatment of psychosis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEUROLEPTIC AGENT;
EDITORIAL;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HEALTH PROGRAM;
HUMAN;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
UNITED STATES;
ARTICLE;
CONSUMER ADVOCACY;
DRUG COST;
ECONOMICS;
EVIDENCE BASED MEDICINE;
HEALTH INSURANCE;
LEGAL ASPECT;
POLITICS;
PSYCHOLOGICAL ASPECT;
PSYCHOSIS;
ANTIPSYCHOTIC AGENTS;
CONSUMER ADVOCACY;
DRUG COSTS;
EVIDENCE-BASED MEDICINE;
HUMANS;
LOBBYING;
MANAGED CARE PROGRAMS;
PSYCHOTIC DISORDERS;
UNITED STATES;
|
|
EID: 0032880244
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (1)
|
|
References (3)
|